NCT07796932Not yet recruiting
Characterisation of MNEsic Involvement in Patients With Obesity.
Source: ClinicalTrials.gov · Last updated 1 Sept 2026
Brief summary (registry, in English)
The aim of the study is therefore to characterise memory impairment in a middle-aged population with obesity and to clarify the role of inflammation in obesity-related memory impairment. The hypothesise that, as in an elderly population, neurological and memory impairment in a population of middle-aged obese individuals is heterogeneous, with varying levels of memory impairment characterised by neuropsychological test results. This heterogeneity in neuropsychological tests may be linked to markers of inflammation and brain imaging biomarkers identified previously in the litterature.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 22 Jul 2026
- Start date
- Jan 2027
- Primary completion date
- Feb 2030
- Lead sponsor
- University Hospital, Bordeaux
- Diseases
- Obesity
- NCT number
- NCT07796932
What you commit to
- Study type: Observational
- Planned participants: 150
- From Jan 2027 to the primary completion date, Feb 2030
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients currently undergoing treatment with neuroleptics or who have stopped treatment within the last 3 months.
- Chronic use of NSAIDs or corticosteroids
- Loss of 5% of body weight in the 3 months prior to the study
Other illness
- Known current or past neurological disease
- Proven depressive syndrome treated
- Patients with type 1 or type 2 diabetes
- Acute infection
Other
- Pregnant or breastfeeding patients
- Uncontrolled dysthyroidism
- MMS\< 25
- Patients with proven genetic obesity
- Contraindication to MRI
- Persons deprived of their liberty by judicial or administrative decision
- Adults subject to legal protection measures (guardianship, curatorship, judicial protection)
Who the study is looking for
- Patients suffering from obesity with a BMI between 30 and 45 kg/m²
- Patients aged between 30 and 50 receiving educational care during the week at the CSO (Endocrinology, Diabetology and Nutrition Department) of the Bordeaux University Hospital.
- Right-handed patients
- Persons affiliated with or beneficiaries of a social security scheme.
- Free, informed and express consent
Age in the registry: 30 years to 50 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.